Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in SLE
NCT05260255Completed
- Sponsor
- Ministry of Public Health
- Start
- Jun 2021
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, double-blind trial in systemic lupus erythematosus (SLE) comparing Vitamin D Supplementation with Placebo (2 arms). Primary endpoint: SLE Disease Activity Index 2000 at 12 weeks. Started Jun 2021; status: completed.
02
Drugs
vitamin d
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT05260255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05260255.